APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain-relieving API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pain-relieving API Market Analysis and Forecast 2026-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchPain-relieving API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain-relieving API Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pain-relieving API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain-relieving API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain-relieving API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pain-relieving API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pain-relieving API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pain-relieving API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pain-relieving API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pain-relieving API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pain-relieving API include Xinhua Pharmaceutical, Sanofi, Biocause Heilen, SOLARA, SI Group, Noramco, IOLCP, Biocause and BASF, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pain-relieving API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pain-relieving API, also provides the sales of main regions and countries. Of the upcoming market potential for Pain-relieving API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pain-relieving API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pain-relieving API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pain-relieving API sales, projected growth trends, production technology, application and end-user industry.

Pain-relieving API Segment by Company

Xinhua Pharmaceutical

Sanofi

Biocause Heilen

SOLARA

SI Group

Noramco

IOLCP

Biocause

BASF

Aspen API The Netherlands

Pain-relieving API Segment by Type

Opiate

Non-Opiate

Pain-relieving API Segment by Application

Contract Manufacturing Organizations

Pharmaceutical Companies

Others

Pain-relieving API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain-relieving API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain-relieving API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain-relieving API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pain-relieving API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pain-relieving API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pain-relieving API sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pain-relieving API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Opiate Major Manufacturers Table 3. Non-Opiate Major Manufacturers Table 4. Global Pain-relieving API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Contract Manufacturing Organizations Major Manufacturers Table 6. Pharmaceutical Companies Major Manufacturers Table 7. Others Major Manufacturers Table 8. Pain-relieving API Industry Trends Table 9. Pain-relieving API Industry Drivers Table 10. Pain-relieving API Industry Opportunities and Challenges Table 11. Pain-relieving API Industry Restraints Table 12. Global Pain-relieving API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pain-relieving API Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pain-relieving API Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pain-relieving API Revenue Market Share by Region (2021-2026) Table 16. Global Pain-relieving API Revenue Market Share by Region (2027-2032) Table 17. Global Pain-relieving API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Pain-relieving API Sales by Region (2021-2026) & (K Units) Table 19. Global Pain-relieving API Sales by Region (2027-2032) & (K Units) Table 20. Global Pain-relieving API Sales Market Share by Region (2021-2026) Table 21. Global Pain-relieving API Sales Market Share by Region (2027-2032) Table 22. Global Pain-relieving API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pain-relieving API Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pain-relieving API Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pain-relieving API Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pain-relieving API Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Pain-relieving API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pain-relieving API Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pain-relieving API Manufacturers, Product Type & Application Table 30. Global Pain-relieving API Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pain-relieving API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pain-relieving API Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pain-relieving API Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pain-relieving API Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pain-relieving API Revenue Market Share by Type (2021-2026) Table 37. Global Pain-relieving API Revenue Market Share by Type (2027-2032) Table 38. Global Pain-relieving API Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 40. Global Pain-relieving API Sales by Type (2027-2032) & (K Units) Table 41. Global Pain-relieving API Sales Market Share by Type (2021-2026) Table 42. Global Pain-relieving API Sales Market Share by Type (2027-2032) Table 43. Global Pain-relieving API Price by Type (2021-2026) & (US$/Unit) Table 44. Global Pain-relieving API Price by Type (2027-2032) & (US$/Unit) Table 45. Global Pain-relieving API Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pain-relieving API Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pain-relieving API Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pain-relieving API Revenue Market Share by Application (2021-2026) Table 49. Global Pain-relieving API Revenue Market Share by Application (2027-2032) Table 50. Global Pain-relieving API Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 52. Global Pain-relieving API Sales by Application (2027-2032) & (K Units) Table 53. Global Pain-relieving API Sales Market Share by Application (2021-2026) Table 54. Global Pain-relieving API Sales Market Share by Application (2027-2032) Table 55. Global Pain-relieving API Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pain-relieving API Price by Application (2027-2032) & (US$/Unit) Table 57. Xinhua Pharmaceutical Company Information Table 58. Xinhua Pharmaceutical Business Overview Table 59. Xinhua Pharmaceutical Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Xinhua Pharmaceutical Pain-relieving API Product Portfolio Table 61. Xinhua Pharmaceutical Recent Development Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Sanofi Pain-relieving API Product Portfolio Table 66. Sanofi Recent Development Table 67. Biocause Heilen Company Information Table 68. Biocause Heilen Business Overview Table 69. Biocause Heilen Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Biocause Heilen Pain-relieving API Product Portfolio Table 71. Biocause Heilen Recent Development Table 72. SOLARA Company Information Table 73. SOLARA Business Overview Table 74. SOLARA Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. SOLARA Pain-relieving API Product Portfolio Table 76. SOLARA Recent Development Table 77. SI Group Company Information Table 78. SI Group Business Overview Table 79. SI Group Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. SI Group Pain-relieving API Product Portfolio Table 81. SI Group Recent Development Table 82. Noramco Company Information Table 83. Noramco Business Overview Table 84. Noramco Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Noramco Pain-relieving API Product Portfolio Table 86. Noramco Recent Development Table 87. IOLCP Company Information Table 88. IOLCP Business Overview Table 89. IOLCP Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. IOLCP Pain-relieving API Product Portfolio Table 91. IOLCP Recent Development Table 92. Biocause Company Information Table 93. Biocause Business Overview Table 94. Biocause Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Biocause Pain-relieving API Product Portfolio Table 96. Biocause Recent Development Table 97. BASF Company Information Table 98. BASF Business Overview Table 99. BASF Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. BASF Pain-relieving API Product Portfolio Table 101. BASF Recent Development Table 102. Aspen API The Netherlands Company Information Table 103. Aspen API The Netherlands Business Overview Table 104. Aspen API The Netherlands Pain-relieving API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Aspen API The Netherlands Pain-relieving API Product Portfolio Table 106. Aspen API The Netherlands Recent Development Table 107. North America Pain-relieving API Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Pain-relieving API Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 110. North America Pain-relieving API Sales by Type (2027-2032) & (K Units) Table 111. North America Pain-relieving API Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America Pain-relieving API Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America Pain-relieving API Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Pain-relieving API Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 116. North America Pain-relieving API Sales by Application (2027-2032) & (K Units) Table 117. North America Pain-relieving API Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America Pain-relieving API Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Pain-relieving API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Pain-relieving API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Pain-relieving API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. North America Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 124. North America Pain-relieving API Sales by Country (2027-2032) & (K Units) Table 125. North America Pain-relieving API Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America Pain-relieving API Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 128. Canada Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 129. Europe Pain-relieving API Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Pain-relieving API Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 132. Europe Pain-relieving API Sales by Type (2027-2032) & (K Units) Table 133. Europe Pain-relieving API Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Europe Pain-relieving API Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Europe Pain-relieving API Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Pain-relieving API Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 138. Europe Pain-relieving API Sales by Application (2027-2032) & (K Units) Table 139. Europe Pain-relieving API Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Europe Pain-relieving API Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Europe Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Pain-relieving API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe Pain-relieving API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe Pain-relieving API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Europe Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 146. Europe Pain-relieving API Sales by Country (2027-2032) & (K Units) Table 147. Europe Pain-relieving API Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Europe Pain-relieving API Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Germany Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 150. France Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 151. U.K. Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 152. Italy Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 154. China Pain-relieving API Revenue by Type (2021-2026) & (US$ Million) Table 155. China Pain-relieving API Revenue by Type (2027-2032) & (US$ Million) Table 156. China Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 157. China Pain-relieving API Sales by Type (2027-2032) & (K Units) Table 158. China Pain-relieving API Sales Price by Type (2021-2026) & (US$/Unit) Table 159. China Pain-relieving API Sales Price by Type (2027-2032) & (US$/Unit) Table 160. China Pain-relieving API Revenue by Application (2021-2026) & (US$ Million) Table 161. China Pain-relieving API Revenue by Application (2027-2032) & (US$ Million) Table 162. China Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 163. China Pain-relieving API Sales by Application (2027-2032) & (K Units) Table 164. China Pain-relieving API Sales Price by Application (2021-2026) & (US$/Unit) Table 165. China Pain-relieving API Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Asia Pain-relieving API Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Pain-relieving API Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 169. Asia Pain-relieving API Sales by Type (2027-2032) & (K Units) Table 170. Asia Pain-relieving API Sales Price by Type (2021-2026) & (US$/Unit) Table 171. Asia Pain-relieving API Sales Price by Type (2027-2032) & (US$/Unit) Table 172. Asia Pain-relieving API Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Pain-relieving API Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 175. Asia Pain-relieving API Sales by Application (2027-2032) & (K Units) Table 176. Asia Pain-relieving API Sales Price by Application (2021-2026) & (US$/Unit) Table 177. Asia Pain-relieving API Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Asia Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Pain-relieving API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Pain-relieving API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Pain-relieving API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 182. Asia Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 183. Asia Pain-relieving API Sales by Country (2027-2032) & (K Units) Table 184. Asia Pain-relieving API Sales Price by Country (2021-2026) & (US$/Unit) Table 185. Asia Pain-relieving API Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Japan Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 187. South Korea Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 188. India Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 189. Australia Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 190. China Taiwan Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Pain-relieving API Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Pain-relieving API Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Pain-relieving API Sales by Type (2021-2026) & (K Units) Table 195. SAMEA Pain-relieving API Sales by Type (2027-2032) & (K Units) Table 196. SAMEA Pain-relieving API Sales Price by Type (2021-2026) & (US$/Unit) Table 197. SAMEA Pain-relieving API Sales Price by Type (2027-2032) & (US$/Unit) Table 198. SAMEA Pain-relieving API Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Pain-relieving API Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Pain-relieving API Sales by Application (2021-2026) & (K Units) Table 201. SAMEA Pain-relieving API Sales by Application (2027-2032) & (K Units) Table 202. SAMEA Pain-relieving API Sales Price by Application (2021-2026) & (US$/Unit) Table 203. SAMEA Pain-relieving API Sales Price by Application (2027-2032) & (US$/Unit) Table 204. SAMEA Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Pain-relieving API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Pain-relieving API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Pain-relieving API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. SAMEA Pain-relieving API Sales by Country (2021-2026) & (K Units) Table 209. SAMEA Pain-relieving API Sales by Country (2027-2032) & (K Units) Table 210. SAMEA Pain-relieving API Sales Price by Country (2021-2026) & (US$/Unit) Table 211. SAMEA Pain-relieving API Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Brazil Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 213. Argentina Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 214. Chile Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 215. Colombia Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 216. Peru Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 218. Israel Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 219. UAE Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 220. Turkey Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 221. Iran Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 222. Egypt Pain-relieving API Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Pain-relieving API Distributors List Table 226. Pain-relieving API Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Pain-relieving API Image Figure 2. Global Pain-relieving API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain-relieving API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Opiate Image Figure 5. Non-Opiate Image Figure 6. Global Pain-relieving API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pain-relieving API Market Size Share 2021 VS 2025 VS 2032 Figure 8. Contract Manufacturing Organizations Image Figure 9. Pharmaceutical Companies Image Figure 10. Others Image Figure 11. Global Pain-relieving API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pain-relieving API Revenue (2021-2032) & (US$ Million) Figure 13. Global Pain-relieving API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pain-relieving API Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pain-relieving API Revenue Market Share by Region (2021-2032) Figure 16. Global Pain-relieving API Sales (2021-2032) & (K Units) Figure 17. Global Pain-relieving API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Pain-relieving API Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pain-relieving API Sales YoY (2021-2032) & (K Units) Figure 20. Europe Pain-relieving API Sales YoY (2021-2032) & (K Units) Figure 21. China Pain-relieving API Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Pain-relieving API Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Pain-relieving API Sales YoY (2021-2032) & (K Units) Figure 24. Global Pain-relieving API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Pain-relieving API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Pain-relieving API Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pain-relieving API Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Pain-relieving API Revenue Market Share by Type (2021-2032) Figure 30. Global Pain-relieving API Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Pain-relieving API Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pain-relieving API Sales Market Share by Type (2021-2032) Figure 33. Global Pain-relieving API Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pain-relieving API Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Pain-relieving API Revenue Market Share by Application (2021-2032) Figure 36. Global Pain-relieving API Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Pain-relieving API Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pain-relieving API Sales Market Share by Application (2021-2032) Figure 39. North America Pain-relieving API Revenue Share by Type (2021-2032) Figure 40. North America Pain-relieving API Sales Share by Type (2021-2032) Figure 41. North America Pain-relieving API Revenue Share by Application (2021-2032) Figure 42. North America Pain-relieving API Sales Share by Application (2021-2032) Figure 43. North America Pain-relieving API Revenue Share by Country (2021-2032) Figure 44. North America Pain-relieving API Sales Share by Country (2021-2032) Figure 45. Europe Pain-relieving API Revenue Share by Type (2021-2032) Figure 46. Europe Pain-relieving API Sales Share by Type (2021-2032) Figure 47. Europe Pain-relieving API Revenue Share by Application (2021-2032) Figure 48. Europe Pain-relieving API Sales Share by Application (2021-2032) Figure 49. Europe Pain-relieving API Revenue Share by Country (2021-2032) Figure 50. Europe Pain-relieving API Sales Share by Country (2021-2032) Figure 51. China Pain-relieving API Revenue Share by Type (2021-2032) Figure 52. China Pain-relieving API Sales Share by Type (2021-2032) Figure 53. China Pain-relieving API Revenue Share by Application (2021-2032) Figure 54. China Pain-relieving API Sales Share by Application (2021-2032) Figure 55. Asia Pain-relieving API Revenue Share by Type (2021-2032) Figure 56. Asia Pain-relieving API Sales Share by Type (2021-2032) Figure 57. Asia Pain-relieving API Revenue Share by Application (2021-2032) Figure 58. Asia Pain-relieving API Sales Share by Application (2021-2032) Figure 59. Asia Pain-relieving API Revenue Share by Country (2021-2032) Figure 60. Asia Pain-relieving API Sales Share by Country (2021-2032) Figure 61. SAMEA Pain-relieving API Revenue Share by Type (2021-2032) Figure 62. SAMEA Pain-relieving API Sales Share by Type (2021-2032) Figure 63. SAMEA Pain-relieving API Revenue Share by Application (2021-2032) Figure 64. SAMEA Pain-relieving API Sales Share by Application (2021-2032) Figure 65. SAMEA Pain-relieving API Revenue Share by Country (2021-2032) Figure 66. SAMEA Pain-relieving API Sales Share by Country (2021-2032) Figure 67. Pain-relieving API Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pain-relieving API Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Opiate
  • Non-Opiate
Applications
  • Contract Manufacturing Organizations
  • Pharmaceutical Companies
  • Others
Companies covered
  • Xinhua Pharmaceutical
  • Sanofi
  • Biocause Heilen
  • SOLARA
  • SI Group
  • Noramco
  • IOLCP
  • Biocause
  • BASF
  • Aspen API The Netherlands

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pain-relieving API Market by Type
  3. 1.2.1 Global Pain-relieving API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Opiate
  5. 1.2.3 Non-Opiate
  6. 1.3 Pain-relieving API Market by Application
  7. 1.3.1 Global Pain-relieving API Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Contract Manufacturing Organizations
  9. 1.3.3 Pharmaceutical Companies
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pain-relieving API Market Dynamics
  1. 2.1 Pain-relieving API Industry Trends
  2. 2.2 Pain-relieving API Industry Drivers
  3. 2.3 Pain-relieving API Industry Opportunities and Challenges
  4. 2.4 Pain-relieving API Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pain-relieving API Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pain-relieving API Revenue by Region
  3. 3.2.1 Global Pain-relieving API Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pain-relieving API Revenue by Region (2021-2026)
  5. 3.2.3 Global Pain-relieving API Revenue by Region (2027-2032)
  6. 3.2.4 Global Pain-relieving API Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pain-relieving API Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pain-relieving API Sales by Region
  9. 3.4.1 Global Pain-relieving API Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pain-relieving API Sales by Region (2021-2026)
  11. 3.4.3 Global Pain-relieving API Sales by Region (2027-2032)
  12. 3.4.4 Global Pain-relieving API Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pain-relieving API Revenue by Manufacturers
  2. 4.1.1 Global Pain-relieving API Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pain-relieving API Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pain-relieving API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pain-relieving API Sales by Manufacturers
  6. 4.2.1 Global Pain-relieving API Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pain-relieving API Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pain-relieving API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pain-relieving API Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pain-relieving API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pain-relieving API Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pain-relieving API Manufacturers, Product Type & Application
  13. 4.7 Global Pain-relieving API Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pain-relieving API Market CR5 and HHI
  16. 4.8.2 2025 Pain-relieving API Tier 1, Tier 2, and Tier 3
5 Pain-relieving API Market by Type
  1. 5.1 Global Pain-relieving API Revenue by Type
  2. 5.1.1 Global Pain-relieving API Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pain-relieving API Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pain-relieving API Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pain-relieving API Sales by Type
  6. 5.2.1 Global Pain-relieving API Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pain-relieving API Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pain-relieving API Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pain-relieving API Price by Type
6 Pain-relieving API Market by Application
  1. 6.1 Global Pain-relieving API Revenue by Application
  2. 6.1.1 Global Pain-relieving API Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pain-relieving API Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pain-relieving API Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pain-relieving API Sales by Application
  6. 6.2.1 Global Pain-relieving API Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pain-relieving API Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pain-relieving API Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pain-relieving API Price by Application
7 Company Profiles
  1. 7.1 Xinhua Pharmaceutical
  2. 7.1.1 Xinhua Pharmaceutical Company Information
  3. 7.1.2 Xinhua Pharmaceutical Business Overview
  4. 7.1.3 Xinhua Pharmaceutical Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Xinhua Pharmaceutical Pain-relieving API Product Portfolio
  6. 7.1.5 Xinhua Pharmaceutical Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Pain-relieving API Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Biocause Heilen
  14. 7.3.1 Biocause Heilen Company Information
  15. 7.3.2 Biocause Heilen Business Overview
  16. 7.3.3 Biocause Heilen Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Biocause Heilen Pain-relieving API Product Portfolio
  18. 7.3.5 Biocause Heilen Recent Developments
  19. 7.4 SOLARA
  20. 7.4.1 SOLARA Company Information
  21. 7.4.2 SOLARA Business Overview
  22. 7.4.3 SOLARA Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 SOLARA Pain-relieving API Product Portfolio
  24. 7.4.5 SOLARA Recent Developments
  25. 7.5 SI Group
  26. 7.5.1 SI Group Company Information
  27. 7.5.2 SI Group Business Overview
  28. 7.5.3 SI Group Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SI Group Pain-relieving API Product Portfolio
  30. 7.5.5 SI Group Recent Developments
  31. 7.6 Noramco
  32. 7.6.1 Noramco Company Information
  33. 7.6.2 Noramco Business Overview
  34. 7.6.3 Noramco Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Noramco Pain-relieving API Product Portfolio
  36. 7.6.5 Noramco Recent Developments
  37. 7.7 IOLCP
  38. 7.7.1 IOLCP Company Information
  39. 7.7.2 IOLCP Business Overview
  40. 7.7.3 IOLCP Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 IOLCP Pain-relieving API Product Portfolio
  42. 7.7.5 IOLCP Recent Developments
  43. 7.8 Biocause
  44. 7.8.1 Biocause Company Information
  45. 7.8.2 Biocause Business Overview
  46. 7.8.3 Biocause Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biocause Pain-relieving API Product Portfolio
  48. 7.8.5 Biocause Recent Developments
  49. 7.9 BASF
  50. 7.9.1 BASF Company Information
  51. 7.9.2 BASF Business Overview
  52. 7.9.3 BASF Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BASF Pain-relieving API Product Portfolio
  54. 7.9.5 BASF Recent Developments
  55. 7.10 Aspen API The Netherlands
  56. 7.10.1 Aspen API The Netherlands Company Information
  57. 7.10.2 Aspen API The Netherlands Business Overview
  58. 7.10.3 Aspen API The Netherlands Pain-relieving API Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Aspen API The Netherlands Pain-relieving API Product Portfolio
  60. 7.10.5 Aspen API The Netherlands Recent Developments
8 North America
  1. 8.1 North America Pain-relieving API Market Size by Type
  2. 8.1.1 North America Pain-relieving API Revenue by Type (2021-2032)
  3. 8.1.2 North America Pain-relieving API Sales by Type (2021-2032)
  4. 8.1.3 North America Pain-relieving API Price by Type (2021-2032)
  5. 8.2 North America Pain-relieving API Market Size by Application
  6. 8.2.1 North America Pain-relieving API Revenue by Application (2021-2032)
  7. 8.2.2 North America Pain-relieving API Sales by Application (2021-2032)
  8. 8.2.3 North America Pain-relieving API Price by Application (2021-2032)
  9. 8.3 North America Pain-relieving API Market Size by Country
  10. 8.3.1 North America Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pain-relieving API Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pain-relieving API Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pain-relieving API Market Size by Type
  2. 9.1.1 Europe Pain-relieving API Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pain-relieving API Sales by Type (2021-2032)
  4. 9.1.3 Europe Pain-relieving API Price by Type (2021-2032)
  5. 9.2 Europe Pain-relieving API Market Size by Application
  6. 9.2.1 Europe Pain-relieving API Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pain-relieving API Sales by Application (2021-2032)
  8. 9.2.3 Europe Pain-relieving API Price by Application (2021-2032)
  9. 9.3 Europe Pain-relieving API Market Size by Country
  10. 9.3.1 Europe Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pain-relieving API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pain-relieving API Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Pain-relieving API Market Size by Type
  2. 10.1.1 China Pain-relieving API Revenue by Type (2021-2032)
  3. 10.1.2 China Pain-relieving API Sales by Type (2021-2032)
  4. 10.1.3 China Pain-relieving API Price by Type (2021-2032)
  5. 10.2 China Pain-relieving API Market Size by Application
  6. 10.2.1 China Pain-relieving API Revenue by Application (2021-2032)
  7. 10.2.2 China Pain-relieving API Sales by Application (2021-2032)
  8. 10.2.3 China Pain-relieving API Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pain-relieving API Market Size by Type
  2. 11.1.1 Asia Pain-relieving API Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pain-relieving API Sales by Type (2021-2032)
  4. 11.1.3 Asia Pain-relieving API Price by Type (2021-2032)
  5. 11.2 Asia Pain-relieving API Market Size by Application
  6. 11.2.1 Asia Pain-relieving API Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pain-relieving API Sales by Application (2021-2032)
  8. 11.2.3 Asia Pain-relieving API Price by Application (2021-2032)
  9. 11.3 Asia Pain-relieving API Market Size by Country
  10. 11.3.1 Asia Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pain-relieving API Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pain-relieving API Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pain-relieving API Market Size by Type
  2. 12.1.1 SAMEA Pain-relieving API Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pain-relieving API Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pain-relieving API Price by Type (2021-2032)
  5. 12.2 SAMEA Pain-relieving API Market Size by Application
  6. 12.2.1 SAMEA Pain-relieving API Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pain-relieving API Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pain-relieving API Price by Application (2021-2032)
  9. 12.3 SAMEA Pain-relieving API Market Size by Country
  10. 12.3.1 SAMEA Pain-relieving API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pain-relieving API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pain-relieving API Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pain-relieving API Value Chain Analysis
  2. 13.1.1 Pain-relieving API Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pain-relieving API Production Mode & Process
  6. 13.2 Pain-relieving API Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pain-relieving API Distributors
  9. 13.2.3 Pain-relieving API Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst